Evidence map›Paper›PMID 33558653›Full record

ArticleNature microbiology2021

Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency.

Boqiang Sun, Xuewei Yang, Fujun Hou, Xiaofeng Yu, Qiongyan Wang, Hyung Suk Oh, Priya Raja, Jean M Pesola, Emilia A H Vanni, Seamus McCarron and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Boqiang Sun *Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China.
Xuewei Yang *Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China.
Fujun Hou *Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China.
Xiaofeng YuDepartment of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China.
Qiongyan WangDepartment of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China.
Hyung Suk OhDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1739-0389
Priya RajaDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Jean M PesolaDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Emilia A H VanniDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3785-7430
Seamus McCarronDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Jenna Morris-LoveDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4853-2175
Alex H M NgWyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5075-9750
George M ChurchWyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3535-2076
David M KnipeDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1554-6236
Donald M CoenDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Dongli PanDepartment of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, China. pandongli@zju.edu.cn.ORCID http://orcid.org/0000-0002-0421-6242
Harvard University · USSir Run Run Shaw Hospital · CNZhejiang Chinese Medical University · CN

Funding

VIral and host mechanisms that tilt the HSV lytic/latent balanceP01AI098681 · NIAID · HARVARD MEDICAL SCHOOL · PI PESOLA, JEAN M · 2013 to 2023
$19.2M
Center for Genomically Engineered OrgansRM1HG008525 · NHGRI · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M · 2015 to 2019
$10.2M
NHGRI NIH HHS RM1 HG008525NIAID NIH HHS P01 AI098681
6 · The paper itself

Abstract

MicroRNA miR-138, which is highly expressed in neurons, represses herpes simplex virus 1 (HSV-1) lytic cycle genes by targeting viral ICP0 messenger RNA, thereby promoting viral latency in mice. We found that overexpressed miR-138 also represses lytic processes independently of ICP0 in murine and human neuronal cells; therefore, we investigated whether miR-138 has targets besides ICP0. Using genome-wide RNA sequencing/photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation followed by short interfering RNA knockdown of candidate targets, we identified the host Oct-1 and Foxc1 messenger mRNAs as miR-138's targets, whose gene products are transcription factors important for HSV-1 replication in neuronal cells. OCT-1 has a known role in the initiation of HSV transcription. Overexpression of FOXC1, which was not known to affect HSV-1, promoted HSV-1 replication in murine neurons and ganglia. CRISPR-Cas9 knockout of FOXC1 reduced viral replication, lytic gene expression and miR-138 repression in murine neuronal cells. FOXC1 also collaborated with ICP0 to decrease heterochromatin on viral genes and compensated for the defect of an ICP0-null virus. In summary, miR-138 targets ICP0, Oct-1 and Foxc1 to repress HSV-1 lytic cycle genes and promote epigenetic gene silencing, which together enable favourable conditions for latent infection.

Indexed as

Virus LatencyAnimalsGene Expression Regulation, ViralHerpes SimplexHerpesvirus 1, HumanHost-Pathogen InteractionsHumansImmediate-Early ProteinsMaleMiceMicroRNAsNeuronsOrganic Cation Transporter 1RNA, ViralUbiquitin-Protein LigasesImmediate-Early ProteinsMicroRNAsMIRN138 microRNA, humanOrganic Cation Transporter 1RNA, ViralUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID33558653
PMCPMC8221016
OpenAlexW3128559611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.